Search

everythinglearnresearchcommunity

for

Search:↓

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Nutraceuticals can effectively manage hormonal imbalances and related health issues.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

Including androgens in hormone therapy may lower breast cancer risk.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

A new method accurately measures long-term hormone levels in hair.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.